Muthoot Finance Investor Presentation for Quarter Ended December 31, 2025
Muthoot Finance announced its Investor Presentation for the quarter ended December 31, 2025 (Q3 FY26), showcasing record performance across…
Honasa Consumer Ltd. Highest-Ever Quarterly Revenue Reported for Q3 FY26
Honasa Consumer Ltd. announced record financial results for the quarter ended December 31, 2025 (Q3 FY26). The company achieved its…
Tega Industries Limited Board Approves Funding and Investment Structure for Proposed Acquisition
Tega Industries Limited’s Board has approved a comprehensive financing structure for its previously announced acquisition. This includes…
MMTC Limited Unaudited Financial Results Declared for Q3 FY2025-26
MMTC Limited announced the approval of its Unaudited Financial Results for the third quarter and nine months ended December 31, 2025. The…
Marksans Pharma Ltd. Q3 FY26 Earnings Call Highlights Steady Growth and Margin Expansion
Marksans Pharma reported a 10.6% year-on-year growth in Q3 FY26 operating revenue, reaching an all-time high of INR 754 crores. The company…
Rashtriya Chemicals and Fertilizers Limited Board Approves Q3 Financial Results and Declares Interim Dividend
The Board of Directors of RCF met on February 12, 2026, to approve the Un-audited Financial Results for the quarter ended December 31, 2025…
Natco Pharma Limited Announces 3rd Interim Dividend of Rs.1.50 for FY 2025-26
Natco Pharma Limited’s Board of Directors has declared the 3rd interim dividend for the financial year 2025-26. Shareholders will…
Honasa Consumer Limited Financial Results Approved for Quarter and Nine Months Ending December 31, 2025
Honasa Consumer Limited’s Board of Directors approved the unaudited standalone and consolidated financial results for the quarter and…
Praj Industries Limited Financial Results for Q3 FY2025 – Standalone & Consolidated Performance
Praj Industries Limited has submitted its Unaudited Financial Results for the third quarter and nine months ended December 31, 2025. The…
NATCO Pharma Limited Board Approves Incorporation of Wholly Owned Subsidiary in Chile
NATCO Pharma Limited has announced a strategic expansion through the incorporation of a new wholly owned subsidiary in Chile, named NATCO…